ArticleBMC gastroenterology2023

Identification of inadequate responders to advanced therapy among commercially-insured adult patients with Crohn's disease and ulcerative colitis in the United States.

Theresa Hunter Gibble et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.